Export 122 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
E. S. Woodle and Group, F. Steroid Wi, “A Prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycopheonlate mofetil therapy with antibody induction”, 2003.
E. Woodle, Van Veldhuisen, P., and , “A Prospective, Randomized, Multicenter, Double-Blind Study of Early Corticosteroid Cessation Versus Long-Term Maintenance of Corticosteroid Therapy with Tacrolimus and Mycophenolate Mofetil in Primary Renal Transplant Recipients: One Year Report”, Transplant Proc, vol. 37, pp. 804-808, 2005.
R. A. Wood, Sicherer, S. H., Vickery, B. P., Jones, S. M., Liu, A. H., Fleischer, D. M., Henning, A. K., Mayer, L., A Burks, W., Grishin, A., Stablein, D., and Sampson, H. A., “The natural history of milk allergy in an observational cohort.”, J Allergy Clin Immunol, vol. 131, no. 3, pp. 805-12, 2013.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., “A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.”, Allergy, vol. 68, no. 6, pp. 803-8, 2013.
R. A. Wood, Sicherer, S. H., Vickery, B. P., Jones, S. M., Liu, A. H., Fleischer, D. M., Henning, A. K., Mayer, L., Burks, A. W., Grishin, A., Stablein, D., and Sampson, H. A., “The Natural History of Milk Allergy in an Observational Cohort”, J Allergy Clin Immunol, vol. 131, pp. 805-812, 2013.
R. Wood, Sicherer, S., Stablein, D., Jones, S., Burks, A., Liu, A., Fleischer, D., Leung, D., Lindblad, R., Sampson, H., and CoFAR), Co.F. A. R. (, “Trends in Milk, Egg, and Peanut IgE Levels Over Time in an Observational Study of Infants with Food Allergy (COFAR2): One Year Follow Up”, Washington DC: , 2009.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., “A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy”, Allergy, vol. 68, pp. 803-808, 2013.
R. A. Wood, Stablein, D., Henning, A. K., Lindblad, R., and Sicherer, S. H., “A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy”, in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 129(2), p. AB27.
R. A. Wood, Kim, J. S., Lindblad, R., Nadeau, K., Henning, A. K., Dawson, P., Plaut, M., and Sampson, H. A., “A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.”, J Allergy Clin Immunol, vol. 137, no. 4, pp. 1103-1110.e11, 2016.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., “Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial”, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
Y. Jo Wong, Keenan, J., Hudson, K., Bryan, H., Naftolin, F., Thompson, V. P., Craig, R. G., Vena, D., Collie, D., Wu, H., Matthews, A. G., Grill, A. C., and Curro, F. A., “Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings.”, Compend Contin Educ Dent, vol. 37, no. 10, pp. 710-718, 2016.
W. T. Wong, Liang, K., Hammel, K., Coleman, H. R., and Chew, E. Y., “Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease”, Ophthalmology, vol. 115, pp. 1957-1964, 2008.
C. S. Wong, Ho, P. L., Stablein, D. M., Alexander, S., Warady, B., Tejani, A., and Watkins, S. L., “Risk factors for anemia during erythropoietin therapy among pediatric dialysis patients: a North American Pediatric Cooperative Study (NAPRTCS) Report”, 2001.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., and Chew, E. Y., “Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C., Ferris, F. L., and Chew, E. Y., “Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial”, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
W. T. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C. B., Cukras, C., Chew, E. Y., Sadda, S. V. R., and Ferris, F. L., “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
W. T. Wong, Liang, K. J., Hammel, K., Coleman, H. R., and Chew, E. Y., “Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.”, Ophthalmology, vol. 115, no. 11, pp. 1957-64, 2008.
M. Wolff, Moulton, L. H., Newcomer, W., Reid, R., and Santo, S. M., “A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children”, AM J Trop Med Hug, vol. 60, pp. 263-6, 1999.
M. C. Wolff, Moulton, L. H., Newcomer, W., Reid, R., and Santosham, M., “A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children.”, Am J Trop Med Hyg, vol. 60, no. 2, pp. 263-6, 1999.
U. E. K. Wolf-Schnurrbusch, Leung, I., Sallo, F. B., Clemons, T. E., Chew, E. Y., Bird, A. C., and Peto, T., “Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”, Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
J. S. Wittenborn, Clemons, T., Regillo, C., Rayess, N., Kruger, D. Liffmann, and Rein, D., “Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.”, JAMA Ophthalmol, vol. 135, no. 5, pp. 452-459, 2017.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., “Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.”, Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
P. L. Winokur, Patel, S. M., Brady, R., Chen, W. H., El-Kamary, S. S., Edwards, K., Creech, C. B., Frey, S., Keitel, W. A., Belshe, R., Walter, E., Bellamy, A., Hill, H., and Group, T. V. T. E. U. - H. 3Nv, “Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine”, J Infect Dis, vol. 212, pp. 525-530, 2015.
P. L. Winokur, Chaloner, K., Doern, G. V., Ferreira, J., and Apicella, M. A., “Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.”, J Infect Dis, vol. 208, no. 5, pp. 728-38, 2013.
P. L. Winokur, Chaloner, K., Doem, G. V., Ferreira, J., and Apicella, M. A., “Safety and Immunological Outcomes Following Human Inoculation with Nontypeable Haemophilus Influenzae”, J Infect Dis, vol. 208, pp. 728-738, 2013.